Cocoa-rich Bioflavanol Supplementation Effects During Cold Exposure
NCT ID: NCT04359082
Last Updated: 2021-04-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
40 participants
INTERVENTIONAL
2020-01-13
2021-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Macro- and Microvascular Response to Cocoa Flavanols in Healthy and Type 2 Diabetes
NCT05449782
Cocoa Flavanols and Painfree Walking Distance
NCT01064583
The Effects of Cocoa Flavanols on Insulin Resistance in an 'At-risk' Population
NCT01201590
Effect of Flavanol-rich Cocoa on Peripheral and Cerebral Blood Flow in Type 2 Diabetes
NCT01654172
Cocoa and Metabolic Health in Prediabetes
NCT02203240
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Placebo
Placebo for 8 straight days
Placebo Pill
Placebo pill has no bioflavanols with 30 mg theobromine and 10 mg caffeine
Bioflavanol
Bioflavanol supplementation for 8 days at 900 mg flavanol per day
CocoaVia supplement
CocoaVia is a dietary supplement that has concentrated bioflavanols of 225 mg flavanols per pill along with 30 mg theobromine and 10 mg caffeine
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CocoaVia supplement
CocoaVia is a dietary supplement that has concentrated bioflavanols of 225 mg flavanols per pill along with 30 mg theobromine and 10 mg caffeine
Placebo Pill
Placebo pill has no bioflavanols with 30 mg theobromine and 10 mg caffeine
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Refrain from the following for 2 weeks before and during the study (including the washout period): consumption of flavanol rich foods including cocoa, chocolate, apples, red, white, and sweet wine, apricots, blueberries, peaches/nectarines, plums, grapes, strawberries, pecans (no more than ½ cup/day, pistachios, (no more than ½ cup per day), and apple juice.
* Participants not to change their daily intakes of tea (green or black) or coffee.
Exclusion Criteria
* Raynaud's syndrome.
* Cold-induced asthma/bronchospasm
* Difficulty swallowing pills.
* Previous hand/finger injuries that impair dexterity and hand function.
* Metal hardware (plates/screws) in the forearms and hands.
* Blood donation in last 8 weeks.
* Medicine use (including any over the counter medication such as Tylenol, Advil, Sudafed, etc…), with the exception of birth control and a multi-vitamin.
* Known allergies to medical adhesives or cocoa/chocolate.
* History of disease of the gastrointestinal tract including (but not limited to) diverticulosis, diverticulitis and inflammatory bowel disease, peptic ulcer disease, Crohn's disease, ulcerative colitis; or previous gastrointestinal surgery.
* No planned MRI during the study or within 2 days after completing a cold test.
* Use of dietary supplements (to include probiotics and prebiotics), with exception of multi-vitamin containing up to 100% of the recommended daily allowance (RDA).
* No exercise or smoking within 8 hours of testing.
* Pregnant or breastfeeding.
* Oral antibiotic use within 3 months of study participation.
* Inability or unwillingness to not consume fermented food products or prebiotic-containing food products for 2 weeks prior to and throughout study participation. Examples include kefir, kombucha, aged cheese, pickles, sauerkraut, sour cream, tempeh, yogurt, kimchi, miso, vinegar, sourdough bread, wine and beer.
* Colonoscopy within 3 months of study participation.
* On average has a bowel movement less frequently than every other day.
18 Years
49 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
United States Army Research Institute of Environmental Medicine
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
John W Castellani, PhD
Role: PRINCIPAL_INVESTIGATOR
US Army Research Institute of Environmental Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
John W Castellani
Natick, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Alba BK, Greenfield AM, Yurkevicius BR, Jones ML, Castellani JW. Short-term cocoa bioflavanol supplementation does not improve cold-induced vasodilation in young healthy adults. Eur J Appl Physiol. 2024 May;124(5):1523-1534. doi: 10.1007/s00421-023-05380-4. Epub 2023 Dec 27.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Informed Consent Form: CIVD
Document Type: Informed Consent Form: Cold Air
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
18-27-H
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.